RecruitingNCT02685969

Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Principal Investigator
Jose Luis Molinuevo, MD, PhD, M.D
Scientific Director
Intervention
18F-Flutemetamol & 18F-FDG(procedure)
Enrollment
570 enrolled
Eligibility
45-75 years · All sexes
Timeline
2017 – 2027

Study locations (1)

Collaborators

Hospital Clinic of Barcelona · General Electric

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02685969 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials